CLEO Systems, who have recently launched its innovative CLEO SOLO EPS electronic prescription service, will be exhibiting at the HETT digital healthcare show in London’s ExCeL on 27th and 28th September on stand F28.
The company will be using this opportunity to showcase their latest successes, which include completing a successful First of Type pilot with Midlands Partnership Foundation NHS Trust (MPFT) and achieving accreditation from NHS Digital EPS with its CLEO SOLO EPS electronic prescription service.
HETT 2022 brings together a wide range of speakers, exhibitors and digital health experts to explore the systems and infrastructure that underpin and enable a data-driven NHS through the meaningful implementation of technology. Exhibiting at HETT 2022 will give CLEO Systems the opportunity to demonstrate the capabilities of its solutions, including CLEO SOLO EPS, which enables quick, seamless, clinically safe prescribing. The team will be sharing with customers and visitors to the stand about how CLEO SOLO EPS can be used in a wide range of outpatient secondary care settings, and enabling patients’ prescriptions to be entered and sent electronically to a nominated community pharmacy of a patient’s choice, encouraging sustainability, reducing prescribing errors and making life easier for clinicians and patients alike.
David Brown, Managing Director, CLEO Systems said, We’ve had a busy and rewarding year and are really looking forward to sharing our developments and successes with those attending HETT in September.’